15 Year Anniversary for Israel's Biomed Week
FIVE HUNDRED CHINA-ISRAELI B2B MEETINGS HELD DURING ISRAELI BIOMED
CONFERENCE
Ministry of Economy & Industry

The 15th Annual Israeli Biomed Week Took Place this Week. The Conference,
with the Participation of the Israeli Innovation Authority, Hosts
Representatives of Leading Companies, Senior Lecturers and Hundreds of
Guests Involved in Life Sciences from Israel and Around the World Every
Year. The Centerpiece of the Conference: a Unique Event with Chinese
Investors Showcasing Israeli Companies to the Chinese Market.

JERUSALEM. May 26th, 2016 – The world renowned Israeli Biomed Conference
hosts representatives of leading companies, senior lecturers and hundreds of
guests involved in the life sciences from Israel and around the world every
year. The events of Israel Biomed Week enable Israeli companies to create
business ties and opportunities and to maximize exposure for their most
innovative products and developments.

As part of the effort to showcase Israeli companies to the Chinese market, a
number of important delegations from China arrived this week to the
conference as guests of the Israel Innovation Authority. Unique among these
is a delegation of investment bodies (both private and funds) with diverse
fields of interest including life sciences, IT and cleantech. In addition,
some 20 Chinese companies in the fields of medical equipment,
pharmaceuticals and agricultural technology from the provinces of Sichuan,
Shandong and Zhejiang sent representatives to the conference. The arrival of
these delegations is a result of the close cooperation between the Israel
Innovation Authority, Chinese provincial governments and the federal
Ministry of Science and Technology of the People's Republic of the China.

In a unique event sponsored by the Israel Innovation Authority in Tel Aviv,
some 500 B2B meetings took place, aimed at forging business ties between
Chinese and Israeli companies and at encouraging Chinese investment in
Israeli companies. The meetings, scheduled in advance, are an important
platform for creating business cooperation, investments, research and
development and more. They also help Israeli companies maximize their
exposure in the Chinese market. Among the leading investment agencies in
attendance: PingAn, Biossom Investment Co and Chengdo Kanghong
Pharmaceutical Group, owner of seven Chinese pharmaceutical companies. Each
of these investment bodies manages investments totaling c. $500 million.

Ahead of the unique Chinese-Israeli meetings, the Chairman of the Israel
Innovation Authority, Mr. Avi Hasson, spoke about the future of Israel's
biomed industry.

Avi Luvton, Asia Pacific Director at the Israel Innovation Authority, said:
"The arrival of the investor delegation is especially important and aims at
creating meetings between Israeli companies and potential Chinese investors.
The group of high quality investors invited to the B2B meeting event was
carefully selected to create real opportunities for cooperation with the
Israeli companies taking part in the event. We were happy to see that there
was great demand on the side of Israeli companies and we did our best to
enable as large a number of Israeli companies as possible to take part in
this unique event."

The 15th annual Israel Biomed Conference is an international conference with
the participation of life science and technology companies from around the
world. The conference is organized by the Israel Advanced Technology
Industries (IATI), an umbrella organization of the hi-tech and life science
industries, and Kenes Exhibitions, a company specializing in conference
productions. The conference was attended by Israel Innovation Authority
Chairman and Chief Scientist Avi Hasson and GM, Early Stage Companies and
Incubators at the Israel Innovation Authority, Anya Eldan.